Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS

Every Aarey Drugs & Pharmaceuticals Limited result whose ten-session window has closed, judged against the last read made before it. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →

21results judged

0read right

0read wrong

0flat / no call

21unread

33%beat the market

-1.4%avg vs market, 10d

3.2%avg move, T+1

How the reads on it fared

Read	Judged	Right	Wrong	Flat	Hit rate	Avg vs mkt
unread	21	0	0	0	—	-1.4%

A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.

Reading the rows

T+1: the share's move on the first session after the result, from the close before it
T+10: the move over ten sessions, same base
vs market: T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
Run-up: the share's move in the thirty sessions before the result
Result: reported profit growth against the company's own last four quarters: good, in line, bad

Each result

21 judged · newest first · open one

Result	Read	Outcome	T+1	T+10	vs market	Run-up	Result	Why
14 Aug Q1FY27	—	unread	-2.0%	+5.2%	+6.3%	-1%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Volume ran 2.4x its prior month in the fortnight before. 1 more	›
29 May Q4FY26	—	unread	-3.1%	+1.7%	+0.4%	+0%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. No read was made before this result; recorded for the base rate.	›
11 Feb Q3FY26	—	unread	-1.5%	+15.7%	+17.5%	-0%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. No read was made before this result; recorded for the base rate.	›
13 Nov Q2FY26	—	unread	+0.1%	-9.5%	-10.8%	+20%	no figures	Ran up 20% in the 30 sessions before the result — a good number had little left to reward. No reported figures on file for this quarter, so the result itself could not be judged. 2 more	›
13 Aug Q1FY26	—	unread	+1.5%	-2.1%	-2.1%	-8%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. No read was made before this result; recorded for the base rate.	›
30 May Q4FY25	—	unread	-2.7%	+6.1%	+5.3%	-2%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. No read was made before this result; recorded for the base rate.	›
14 Feb Q3FY25	—	unread	-9.1%	-17.3%	-13.6%	-25%	no figures	Fell 25% in the 30 sessions before the result — expectations were already low. The market itself moved -3.7% over the same ten sessions; the raw move is mostly tide. 2 more	›
14 Nov Q2FY25	—	unread	-1.9%	+12.0%	+8.9%	-18%	no figures	Fell 18% in the 30 sessions before the result — expectations were already low. The market itself moved +3.2% over the same ten sessions; the raw move is mostly tide. 2 more	›
14 Aug Q1FY25	—	unread	+5.7%	+19.9%	+15.3%	+23%	no figures	Ran up 23% in the 30 sessions before the result — a good number had little left to reward. The market itself moved +4.5% over the same ten sessions; the raw move is mostly tide. 3 more	›
31 May Q4FY24	—	unread	-1.8%	-2.4%	-6.8%	+4%	no figures	The market itself moved +4.3% over the same ten sessions; the raw move is mostly tide. No reported figures on file for this quarter, so the result itself could not be judged. 2 more	›
14 Feb Q3FY24	—	unread	+5.7%	-4.1%	-4.8%	-17%	no figures	Fell 17% in the 30 sessions before the result — expectations were already low. No reported figures on file for this quarter, so the result itself could not be judged. 1 more	›
11 Nov Q2FY24	—	unread	-2.9%	-5.6%	-9.0%	+5%	no figures	The market itself moved +3.5% over the same ten sessions; the raw move is mostly tide. No reported figures on file for this quarter, so the result itself could not be judged. 1 more	›
14 Aug Q1FY24	—	unread	-7.5%	-3.2%	-2.8%	+44%	no figures	Ran up 44% in the 30 sessions before the result — a good number had little left to reward. No reported figures on file for this quarter, so the result itself could not be judged. 4 more	›
31 May Q4FY23	—	unread	+4.8%	+6.8%	+5.6%	+9%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. No read was made before this result; recorded for the base rate.	›
8 Feb Q3FY23	—	unread	-4.4%	-17.6%	-15.6%	-11%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. No read was made before this result; recorded for the base rate.	›
15 Nov Q2FY23	—	unread	-3.5%	-3.7%	-5.3%	+6%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Delivery share rose 5 points in the fortnight before — someone was taking stock home. 2 more	›
13 Aug Q1FY23	—	unread	-4.2%	+5.9%	+5.5%	+12%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Volume ran 1.7x its prior month in the fortnight before. 1 more	›
31 May Q4FY22	—	unread	+0.4%	-5.2%	+0.2%	-21%	no figures	Fell 21% in the 30 sessions before the result — expectations were already low. The market itself moved -5.4% over the same ten sessions; the raw move is mostly tide. 2 more	›
8 Feb Q3FY22	—	unread	-2.4%	-18.1%	-16.9%	+25%	no figures	Ran up 25% in the 30 sessions before the result — a good number had little left to reward. No reported figures on file for this quarter, so the result itself could not be judged. 1 more	›
13 Nov Q2FY22	—	unread	-0.1%	-7.6%	-1.5%	-1%	no figures	The market itself moved -6.2% over the same ten sessions; the raw move is mostly tide. No reported figures on file for this quarter, so the result itself could not be judged. 2 more	›
11 Aug Q1FY22	—	unread	+2.5%	-3.0%	-5.2%	—	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Went into the result within 5% of its 52-week low. 2 more	›